-
Sanofi to bring 5 of its best-selling drugs to India
01 Apr 2024 14:51 GMT
… , Allegra, Enterogermina, Combiflam Cardace and Cerezyme, among others.
Globally, the company … potential in diabetes treatments through a mix of remedial options that comprise … brands, including Frisium anti-epileptic drugs through its partnership with Cipla …
-
Neuronopathic therapies are a serious unmet need in the treatment of Gaucher disease
19 Oct 2023 12:16 GMT
… ERTs include Sanofi’s Cerezyme (imiglucerase), Takeda’s … the creation of drugs designed to cross … with fast-track FDA designation, PR001 treatment could significantly … Looking ahead, collaboration between pharmaceutical innovators, dedicated researchers, …
-
Carina Biotech Appoints Two New U.S. Based Biotechnology Executives to the Board of Directors
05 Jun 2023 12:00 GMT
… .S. Food and Drug Administration (FDA) approved CAR-T … consulting group focused on pharmaceutical and biotech industries. Previously, … several vital therapies, including Cerezyme for Gaucher disease, … for use in the treatment of hyperphosphatemia, and Campath …
-
Top 10 Best Pharmaceutical Companies in Europe 2023
09 Apr 2023 22:34 GMT
… saving drugs and therapies. Pharmaceuticals are a type of medication or drug … drugs, including oncology, cardiology, and neurology treatments.
Novartis is a leading global pharmaceutical … , a treatment for Fabry disease, and Cerezyme, a treatment for Gaucher …
-
Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors
30 Mar 2023 12:33 GMT
… , a clinical-stage biotechnology company pioneering a new … s Phase 1 trial, I believe this drug, with its … to develop an innovative treatment option for Type 2 … Group plc, OncoMed Pharmaceuticals, Inc., X4 Pharmaceuticals, GenSight Biologics, LogicBio …
-
April - June 2023 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
10 Feb 2023 08:45 GMT
… labels that contribute to wrong drug errors
FDA is evaluating the need … replacement therapy
Brineura (cerliponase alfa)
Cerezyme (imiglucerase)
Elelyso (taliglucerase alfa)
Fabrazyme … labels that contribute to wrong drug errors
FDA is evaluating the need …
-
Sanofi: Reliance On One Drug Strategy May Bite
27 May 2022 06:59 GMT
… pharmaceuticals, vaccines, and consumer healthcare. Although it has a large drugs … include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, … Earlier this month FDA approved Dupixent to treat … is the first approved treatment against EoE, and …
-
Drug Manufacturers Continue to Increase Drug Prices Through Third Week of January
26 Jan 2022 11:00 GMT
… adjunctive therapy to antidepressants in adults with … – indicated for the treatment of adults with moderate … with global clients including biotech, pharmaceuticals, government agencies, consultancies, … leading provider of drug and medical device knowledge …
-
Takeda brings drugs for 3 rare diseases to India, but pricing concerns remain
15 Jul 2019 16:52 GMT
… — Velaglucerase Alfa for treatment of Gaucher, Agalsidase Alfa … to VPRIV from Cerezyme recorded better haemoglobin … said. “Doctors forward applications to procure drugs under … and Drug Administration granted Takeda (erstwhile Shire Pharmaceuticals) approval …
-
Gaucher Disease Drugs Market Is Expected To Reach $1.71 Billion By 2025:Grand View Research, Inc.
05 May 2019 11:48 GMT
… amp;rsquo;s Cerezyme. However, GD treatment is witnessing a … Cerezyme and Cerdelga Browse More Reports in Pharmaceuticals … demand for specialty generic drugs. Infectious … Replacement Therapy Gaucher Disease Drugs Country Outlook (Revenue, …